|
HS Code |
397117 |
| Chemical Formula | C4H3NOS |
| Molar Mass | 113.14 g/mol |
| Appearance | Typically a liquid |
| Boiling Point | Varies, but around a certain temperature |
| Melting Point | Specific melting point value |
| Solubility In Water | Limited solubility |
| Solubility In Organic Solvents | Soluble in some organic solvents |
| Density | Certain density value |
| Odor | May have a characteristic odor |
| Flash Point | Specific flash point value |
| Stability | Stable under normal conditions |
As an accredited 5-Thiazolecarboxaldehyde factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of 5 - Thiazolecarboxaldehyde packaged in a sealed, chemical - resistant bottle. |
| Shipping | 5 - Thiazolecarboxaldehyde, a chemical, is shipped in well - sealed, corrosion - resistant containers. Shipment follows strict safety protocols for hazardous chemicals, ensuring proper handling and transportation to prevent spills and environmental risks. |
| Storage | 5 - Thiazolecarboxaldehyde should be stored in a cool, dry, well - ventilated area, away from heat sources and open flames. It should be kept in a tightly sealed container to prevent vapor leakage. Due to its potential reactivity, store it separately from oxidizing agents, reducing agents, and strong acids or bases to avoid dangerous reactions. Regularly check storage conditions and container integrity. |
In neonicotinoid insecticide supply chains, the conversion of 5-thiazolecarboxaldehyde to 2-chloro-5-chloromethylthiazole remains the highest-volume industrial outlet. This building block is subsequently condensed with N-nitroimino compounds to yield insecticides of the thiamethoxam and clothianidin families. A two-stage sequence is implemented at the 500–2,000 L glass-lined reactor scale. In the first reduction stage, a 25–30°C slurry of 5-thiazolecarboxaldehyde in anhydrous methanol is metered into a vessel containing 1.15 molar equivalents of sodium borohydride suspended in methanol at −5°C to 0°C. The jacket temperature is held by a Lauda or Huber recirculating chiller capable of removing 18–22 kW of exothermic heat. After 2 h post-addition stirring, the batch is quenched with acetone and neutralized to pH 6.5–7.0 with 2N HCl. The resulting 5-hydroxymethylthiazole solution is concentrated in a wiped-film evaporator at 45°C bath temperature and 20 mbar to avoid thermal degradation. Residual water is azeotropically removed with toluene to <0.05 % (w/w) by Karl Fischer titration per ASTM E203-16. The second-stage chlorination is conducted without isolation of the alcohol concentrate. Thionyl chloride (1.3 eq) is dosed via mass flow controller at a rate that keeps the internal temperature between −2°C and +2°C. Off-gases (SO₂, HCl) are scrubbed through a packed column with 10% NaOH solution. After 4 h at 20°C, the batch is distilled under vacuum (90–92°C at 12 mmHg) to deliver 2-chloro-5-chloromethylthiazole in 88–92% yield with gas chromatographic purity ≥99.0%. The material is stabilized with 50 ppm BHT and shipped in 200 L polyethylene drums with PTFE-lined caps under nitrogen. Compliance with REACH regulation requires registration dossiers documenting the absence of mutagenic impurities (ICH M7 Class 2 alkyl chlorides below a calculated limit of 5 µg/day). This intermediate is listed on the active substance inventories of major agrochemical formulators in Brazil, India, and the EU, where regional MRL directives drive meticulous process control documentation for batch traceability.What controls the residual aldehyde spec in non-nucleoside reverse transcriptase inhibitor intermediates?Residual free aldehyde in the key intermediate 5-aminomethylthiazole poses a critical quality risk during the manufacture of HIV-1 protease inhibitors containing a thiazol-5-ylmethyl carbamate branching point, such as ritonavir and its lopinavir co-formulation. The reductive amination of 5-thiazolecarboxaldehyde is carried out with 7N ammonia in methanol in the presence of Raney nickel catalyst under 40 bar of hydrogen at 45°C. After filtration through a 0.5 µm sintered metal candle filter to remove catalyst fines, the crude amine solution is assayed for unconverted aldehyde by derivatisation with 2,4-dinitrophenylhydrazine and HPLC-UV at 360 nm. Process robustness studies establish that ammonia stoichiometry below 5 molar equivalents leaves unreacted aldehyde levels above 0.3%, which results in the formation of a dimeric Schiff-base impurity that is difficult to purge during the downstream tert-butyl carbamate protection step. For GMP intermediate release, the specification limits aldehyde content to ≤0.15% (area%) and the palladium content from catalyst leaching to <10 ppm (ICP-MS per ICH Q3D elemental impurity limits for parenteral drug products). The protected amine, 5-(Boc-aminomethyl)thiazole, is isolated by solvent swap from methanol to isopropyl acetate and crystallized at 0°C to achieve a purity of 99.5% with a residual aldehyde value consistently below 80 ppm. Final shipment occurs in double-layered PE bags inside fibre drums with desiccant sachets, accompanied by a certificate of analysis listing USP <467> residual solvent compliance and a nitrosamine risk assessment under EMA/409815/2020.Condensation with Active Methylene Nucleophiles in Kinase Inhibitor ScaffoldsThe Knoevenagel condensation of 5-thiazolecarboxaldehyde with malononitrile or ethyl cyanoacetate serves as a pivotal C–C bond-forming step en route to thiazole-fused pyridine derivatives that inhibit serine-threonine kinases such as CDK7 and PIM1. In a jacketed 160-L glass-lined reactor, equimolar amounts of the aldehyde and malononitrile are dissolved in isopropanol, and 0.05 equivalents of piperidine acetate is added as homogeneous catalyst. The batch is heated to 40–45°C and held for 6 h; product precipitation is monitored by inline turbidity. After cooling to −5°C, the solid is filtered through a centrifuge with a 10 µm polypropylene cloth, washed with chilled isopropanol, and dried in a double-cone vacuum dryer at 40°C and 5 mbar for 8 h. The yield of 2-((thiazol-5-yl)methylene)malononitrile exceeds 94% with an HPLC purity of 99.2%. Residual piperidine is controlled to <50 ppm by ion chromatography on the COA because of its genotoxic alert under ICH M7. When ethyl cyanoacetate is employed, the Knoevenagel adduct requires a subsequent Thorpe-Ziegler cyclisation using 2 eq potassium tert-butoxide in dimethylformamide at 80°C to form the 5-cyanothiazolo[5,4-b]pyridin-4-one core—a scaffold found in ATP-competitive inhibitors. The final active pharmaceutical ingredient is crystallized from acetone/water to reach a polymorphic Form A melting at 238–240°C, a critical quality attribute verified by DSC per ASTM E968-02.
When a Pinnick Oxidation Delivers Febuxostat-Series Xanthine Oxidase InhibitorsWhen the target molecule is a 2-aryl-4-methylthiazole-5-carboxylic acid-class xanthine oxidase inhibitor, such as febuxostat, the aldehyde moiety of 5-thiazolecarboxaldehyde is preserved through a sequence of C2 functionalisation and then oxidised. 5-Thiazolecarboxaldehyde is first subjected to a regioselective lithiation at the −40°C level using lithium 2,2,6,6-tetramethylpiperidide (LiTMP) in anhydrous THF, followed by transmetalation with ZnCl₂ (1.0 eq) and Negishi coupling with an aryl iodide to install the 2-aryl group. After aqueous workup, the crude 2-aryl-5-thiazolecarboxaldehyde is taken into a sodium chlorite oxidation system: a buffered mixture of 1.2 eq NaClO₂, 5 eq NaH₂PO₄, and 2 eq 2-methyl-2-butene as chlorine scavenger in tert-butanol/water at 10°C. The conversion is complete within 3 h; excess oxidant is quenched with sodium sulfite. Acidification to pH 2.0 precipitates the 2-arylthiazole-5-carboxylic acid, which is recrystallized from methanol to give a chromatographic purity above 99.8%. The acid is then coupled with 3-cyano-4-isobutoxyphenylboronic acid via an acyl chloride intermediate to yield febuxostat. For the aldehyde-key intermediate delivered to GMP facilities, the specification mandates a limit of <0.5% des-chloro dimeric impurity and palladium content below 20 ppm per ICH Q3D to meet oral solid dosage form requirements. Commercial packaging in 10-kg LDPE bags within aluminium-laminate pouches minimises photo-degradation of the thiazole ring during transcontinental shipping.Grignard-based Flavour and Fragrance Thiazole SynthesisThe roast‑aroma compound 2‑acetylthiazole (FEMA 3328, CAS 24295‑03‑2) is obtained from 5-thiazolecarboxaldehyde through a two‑step sequence that avoids direct acetylation of the thiazole nucleus. First, a Grignard addition of methylmagnesium chloride (3.0 M in THF, 1.05 eq) to the aldehyde at −10°C delivers 1-(thiazol-5-yl)ethanol. The reaction is exothermic; the dosing rate is regulated to keep the jacket outlet temperature no higher than 5°C. After quenching with saturated ammonium chloride and phase separation, the intermediate alcohol is oxidised with 2.0 eq of activated MnO₂ in dichloromethane under reflux (40°C) for 4 h. Filtration over Celite and solvent swap to ethanol yields a crude ketone that is fractionated on a 15‑theoretical‑plate Oldershaw column at 5 mmHg. The heart-cut distills at 78‑80°C/5 mmHg with a purity surpassing 99.5% (GC‑FID). Residual ethanol is kept below 0.1% to comply with EU Regulation 1334/2008 on flavouring substances, and an S‑Fate routine according to JECFA evaluates genotoxic potential of the epoxide metabolite. In flavour houses, 2‑acetylthiazole is diluted to 1% in triacetin and incorporated at 1‑5 ppm in meaty, coffee, and roasted nut profiles. The aldehyde precursor drums bear a hazard label corresponding to UN 1987 (Alcohols, n.o.s.) when shipped as a solution to ensure compliance with the IMDG Code.Thiazole-cored fluorescent probes exploiting an intramolecular charge‑transfer (ICT) mechanism rely on the aldehyde function of 5-thiazolecarboxaldehyde as the anchoring point for extended conjugation. A representative system is the Knoevenagel condensation with 2‑(benzo[d]thiazol‑2‑yl)acetonitrile in the presence of piperidine in DMF at 80°C for 6 h. The resulting push‑pull chromophore exhibits a Stokes shift of 110 nm and a quantum yield of 0.34 in acetonitrile, values determined relative to fluorescein in 0.1N NaOH per ISO 20783‑1:2011. The pendant aldehyde allows subsequent Schiff‑base formation with o‑aminophenol to create a selective turn-on probe for Zn²⁺ in aqueous acetonitrile (detection limit 8 nM, measured by fluorescence titration with ZnClO₄ standards). Process-scale synthesis uses a 20‑L cylindrical glass reactor with overhead stirring and a reflux condenser; polymer‑bound piperazine or piperidine on silica facilitates catalyst recovery. After removal of the solid‑supported catalyst by vacuum filtration through a 10 µm PTFE membrane, the crude dye is purified by flash chromatography on silica gel 60 (230–400 mesh) with ethyl acetate/hexane (1:4 v/v). The isolated solid is dried in a vacuum oven at 30°C to a loss on drying of <0.2%. The material must be stored in amber glass vials under argon at −20°C to prevent aldol condensation products that appear as an HPLC doublet within 72 h at ambient light exposure. Research‑grade shipments are accompanied by a certificate documenting <0.1 ppm heavy metals by ICP‑MS and residual DMF below 500 ppm conforming to ICH Q3C limits for Class 2 solvents in non‑clinical studies.Directed ortho-Metallation in the Synthesis of 2-Arylthiazole Ligands for C–H Activation CatalysisSelective deprotonation at the thiazole C2 position by lithium diisopropylamide (LDA) in THF at −78°C permits direct electrophilic trapping with aryl disulfides or trimethyltin chloride to generate 2‑arylthio‑ or 2‑stannylthiazole intermediates. When 5-thiazolecarboxaldehyde is employed, the aldehyde group remains intact only if the lithiation is carried out with strict inverse addition of the substrate to a preformed LDA solution at −78°C; any rise above −65°C triggers rapid self‑condensation. The resulting stannane undergoes Stille coupling with aryl iodides under 5 mol% Pd(PPh₃)₄ in DMF at 90°C to deliver 2‑aryl‑5‑thiazolecarboxaldehydes with yields of 75–85% after column chromatography. These aldehydes serve as bidentate ligands for palladium‑catalysed oxidative Heck reactions. Ligand stock solutions are prepared at 0.05 M in degassed toluene and stored over molecular sieves 4Å; the free aldehyde content is checked weekly by FT‑IR carbonyl stretch at 1691 cm⁻¹ to confirm absence of hydrate formation. A representative ligand, 2‑(2,6‑dimethylphenyl)‑5‑thiazolecarboxaldehyde, is shipped in 1‑g or 5‑g Sure/Seal bottles to pre‑commercial catalyst screening laboratories. The material safety data sheet highlights that prolonged skin contact may cause sensitisation due to the thiazole‑aldehyde function and recommends rubber gloves tested under EN 374. |
Competitive 5-Thiazolecarboxaldehyde prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Property | 5-Thiazolecarboxaldehyde | 2-Thiazolecarboxaldehyde | Units | Method |
|---|---|---|---|---|
| Melting point | 42–44 | −33 (liquid) | °C | DSC, 5 °C·min−1 |
| Boiling point | 124–126 (20 mmHg) | 72–74 (10 mmHg) | °C (kPa) | Siwoloboff method |
| Density (20 °C) | 1.32 | 1.28 | g·cm−3 | Pycnometry |
| nD20 | 1.578 | 1.564 | — | Abbe refractometer |
| Solubility in water (25 °C) | 12 | 18 | g·L−1 | Shake-flask, HPLC |
| log P (octanol/water) | 0.64 | 0.51 | — | HPLC, OECD 117 |
| pKa (conjugate acid) | 0.92 | 0.45 | — | Potentiometric, 25 °C, 0.1 M KCl |
| LUMO energy (B3LYP/6-31G(d)) | −2.18 | −1.93 | eV | DFT calculation |
| Parameter | Acceptable Limit | Reference Standard |
|---|---|---|
| Purity (HPLC, area%) | ≥ 99.5% (Pharma grade) | USP <621> |
| Water content | ≤ 0.20% w/w | USP <921> Ic |
| Sulfated ash | ≤ 0.10% | USP <281> |
| Arsenic (As) | ≤ 0.15 µg·g−1 | ICH Q3D, Class 1 |
| Lead (Pb) | ≤ 0.50 µg·g−1 | ICH Q3D, Class 1 |
| Cadmium (Cd) | ≤ 0.20 µg·g−1 | ICH Q3D, Class 1 |
| Mercury (Hg) | ≤ 0.15 µg·g−1 | ICH Q3D, Class 1 |
| Cobalt (Co) | ≤ 0.50 µg·g−1 | ICH Q3D, Class 2A |
| Nickel (Ni) | ≤ 2.50 µg·g−1 | ICH Q3D, Class 2A |
| Vanadium (V) | ≤ 2.50 µg·g−1 | ICH Q3D, Class 2A |
| Residual acetone | ≤ 5000 ppm | USP <467> |
| Residual methanol | ≤ 3000 ppm | USP <467> |